| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/29/2003 | EP1036074B1 S-oxide tetrahydrothiopyran phenyloxazolidinones |
| 01/29/2003 | EP1033369B1 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 01/29/2003 | EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/29/2003 | EP1028948B1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 01/29/2003 | EP0984966B1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS |
| 01/29/2003 | EP0973735B1 Polyaromatic antiviral compositions |
| 01/29/2003 | EP0918516B1 Methods of preventing skeletal problems in poultry |
| 01/29/2003 | EP0906294B1 Benzoxazinone dopamine d4 receptor antagonists |
| 01/29/2003 | EP0889884B1 1,2,4-triazine derivatives for the inhibition of protein glycosylation |
| 01/29/2003 | EP0888319B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 01/29/2003 | EP0874863B1 3-deoxy-3-descladinose derivatives of erythromycins a and b |
| 01/29/2003 | EP0865284B1 Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders |
| 01/29/2003 | EP0858465B1 Anti-tumoral protein |
| 01/29/2003 | EP0832081B1 Bicyclic-aromatic compounds |
| 01/29/2003 | EP0831868B1 Monitoring efectiveness of topically applied androgens in sjögren's syndrome by dtetecting tgf-beta in tears |
| 01/29/2003 | EP0828483B1 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase |
| 01/29/2003 | EP0817772B1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/29/2003 | EP0753005B1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides |
| 01/29/2003 | EP0706378B1 New pharmaceutical formulation |
| 01/29/2003 | EP0703980B1 Intracellular binding proteins and use thereof |
| 01/29/2003 | EP0666737B1 Transdermal delivery of the eutomer of a chiral drug |
| 01/29/2003 | EP0641795B9 Carbapenem derivative |
| 01/29/2003 | EP0610444B1 Use of a polyhydroxybenzamide or a derivative thereof in the manufacture of a medicament for treating viral infectious diseases |
| 01/29/2003 | EP0572560B1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 01/29/2003 | CN1394206A Novel vitamin D analogues |
| 01/29/2003 | CN1394205A Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 01/29/2003 | CN1394204A Dibenzo [b,f] azepine intermediates |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/29/2003 | CN1394202A Picolinic acid derivatives and their use as fungicides |
| 01/29/2003 | CN1394201A Substituted glutarimides and use thereof IL-12 production inhibitors |
| 01/29/2003 | CN1394143A Saururus chinensis extract for prevention and treatment of neurodegenerative disease |
| 01/29/2003 | CN1394142A Use of cyclic ether for preparation of medicaments affecting glucose tolerance |
| 01/29/2003 | CN1394141A Fulvestrant formulation |
| 01/29/2003 | CN1394140A Prostaglandin compositions and method of treatment for male erectile dysfunction |
| 01/29/2003 | CN1394139A Anticancer agents |
| 01/29/2003 | CN1394138A Hair growth stimulant |
| 01/29/2003 | CN1394137A Pharmaceutical preparations containing dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease |
| 01/29/2003 | CN1394136A Instant granules and process for their formulation |
| 01/29/2003 | CN1393452A Memory clearing protein and its application |
| 01/29/2003 | CN1393449A Thienothiazine compound with anti-inflammatory and antalgic activity and its preparing process and usage |
| 01/29/2003 | CN1393446A 稠合吡唑化合物 Fused pyrazole compounds |
| 01/29/2003 | CN1393444A Compound for treating impotence |
| 01/29/2003 | CN1393438A Taxane derivative and its preparing process and usage |
| 01/29/2003 | CN1393257A Medicine for treating cardiovascular disease |
| 01/29/2003 | CN1393252A Ointment for treating burn and its preparing process |
| 01/29/2003 | CN1393247A Chinese-medicinal ointment for treating burn and scald |
| 01/29/2003 | CN1393224A Application of scutellaria flavone in treating depression |
| 01/29/2003 | CN1393223A Application of Na-ion channel blocker and aspirin in preparing antalgic medicine for mammal |
| 01/29/2003 | CN1393222A Composition for reparing tissue and regenerating organs by internal in-situ culture and regeneration of stem cells |
| 01/29/2003 | CN1393221A Liquid medicine for treating acne |
| 01/29/2003 | CN1393220A Slow releasing microspheres of transcutaneous huperzine A and its derivative or salt for injection and its preparing process |
| 01/29/2003 | CN1393219A Application of tetracyclic coumarin compounds in preparing anti-HIV medicine |
| 01/29/2003 | CN1393218A Biodegradable durable medicine releasing system |
| 01/29/2003 | CN1393217A Release system for hydrophilic medicines containing polyether |
| 01/29/2003 | CN1100063C Ginkgo testa polysaccharide and preparing process of pharmaceutical thereof |
| 01/29/2003 | CN1100062C Medicine for curing presenile dementia and cerebral apoplexy sequelae |
| 01/29/2003 | CN1100058C Novel intermediates and process for manufacture of camptothecin derivatives (CPT-11) and related compounds |
| 01/29/2003 | CN1100057C Chromene compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/29/2003 | CN1100056C Compound for inhibition of gastric acid secretion |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/29/2003 | CN1100047C N3-(5-methyl-iso-oxazole) group-3,4-dihydroxy cinnamide and producing process thereof |
| 01/29/2003 | CN1100046C 喹唑啉衍生物 Quinazoline derivatives |
| 01/29/2003 | CN1100039C Compound and use thereof |
| 01/29/2003 | CN1100036C Prourokinase and urokinase affinity ligand and its usage |
| 01/29/2003 | CN1100033C Phenylthanolaminotetralin carboxamide derivatives |
| 01/29/2003 | CN1100031C Cyclohexane derivatives |
| 01/29/2003 | CN1099894C Vaccine composition for eliciting immune response against N-glycolylated gangliosides and its use |
| 01/29/2003 | CN1099883C Tibeten medicine for treating hepatitis B and its preparing process |
| 01/29/2003 | CN1099872C Application of lung surface active matter to pharmaceutical industry |
| 01/29/2003 | CN1099871C Shuanggan injecta and preparing method thereof |
| 01/29/2003 | CN1099870C Application of Gerd mycomycin in preparing novel grand spectrum anti-virus medicine |
| 01/29/2003 | CN1099869C Photosensibilizers |
| 01/29/2003 | CA2417631A1 Selective pde 2 inhibitors, used as medicaments for improving cognition |
| 01/28/2003 | WO2002018372A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 01/28/2003 | WO2002009757A1 Preventives or remedies for obesity or fatty liver |
| 01/28/2003 | US6512166 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound |
| 01/28/2003 | US6512139 Oxidation inhibitors in prostane derivatives |
| 01/28/2003 | US6512136 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/28/2003 | US6512123 Antiproliferative agents |
| 01/28/2003 | US6512117 Method of preparing a ketone from a narcotic alkaloid having an allyl alcohol moiety comprising: mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the substantial absence of |
| 01/28/2003 | US6512116 No drug resistance; intravenous |
| 01/28/2003 | US6512112 Useful as prodrugs, easily convert to parent amine in vivo; antibiotic activity versus gram negative aerobic and anaerobic bacteria |
| 01/28/2003 | US6512102 Compositions and methods of diagnosis and treatment using casein kinase I |
| 01/28/2003 | US6512101 Branched hydrazone linkers |
| 01/28/2003 | US6512099 Roselipin derivative |
| 01/28/2003 | US6512011 Treating or preventing a recurrence of a herpes viral infection comprising administering an effective amount of bupropion or a physiologically acceptable salt, solvate or enantiomer of; possibly with acyclovir |
| 01/28/2003 | US6512010 Formulations for the administration of fluoxetine |
| 01/28/2003 | US6512009 Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator |
| 01/28/2003 | US6512007 Treatment of inflammatory processes induced by excessive expression of the IL-6-induced acute phase proteins |
| 01/28/2003 | US6512004 Promoters of neural regeneration |
| 01/28/2003 | US6512002 Methods of treatment for premature ejaculation in a male |
| 01/28/2003 | US6512001 D-proline derivatives |
| 01/28/2003 | US6512000 Aminocarbonyl-substituted benzimidazoles having tryptase-inhibitory activity |
| 01/28/2003 | US6511996 Suitable compounds for i.v.-administration due to their intrinsic properties, such as high stability and high solubility in water |
| 01/28/2003 | US6511995 Inhibits collagen synthesis, which is useful for prophylaxis or treatment of fibrosis |
| 01/28/2003 | US6511992 For treating pain or memory deficiencies related to Alzheimer's disease and other neurodegenerative disorders associated with aging |
| 01/28/2003 | US6511991 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/28/2003 | US6511989 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 01/28/2003 | US6511988 Prevention binding of transcription factor tozinc finger binding compounds |